pd1-ligands-goodsell-2016

Creator: David S. Goodsell / RCSB Protein Data Bank
Identity: PD-1 binding its ligands PD-L1 and PD-L2, illustrated by David Goodsell in December 2016. A molecular background illustration; it does not depict atezolizumab or the ATOMIC trial.
Original source page: https://pdb101.rcsb.org/motm/204
Original asset: https://cdn.rcsb.org/pdb101/motm/204/203-PD1_Programmed_Cell_Death_Protein_1-3bik_3bp5.jpg
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/)
Reuse basis: RCSB usage-policy page explicitly licenses Molecule of the Month illustrations CC BY4.0. Original image article attributes this illustration to Goodsell, December2016, doi:10.2210/rcsb_pdb/mom_2016_12.
Original SHA-256: 679303baf01415486e63761a08b71d772b2d535670fb2b71c3c02bd5e3f480ef
Original dimensions: 543 × 700
Checked at: 2026-10-09T20:03:42.810Z
Modifications: none; display resizing only.
Editorial limitation: Shows the immune-checkpoint molecular contact relevant to anti-PD-L1 therapy. Article photo caption must avoid depicting the PD1 antibody pembrolizumab as atezolizumab; this selected first image contains no drug.

Served SHA-256: 679303baf01415486e63761a08b71d772b2d535670fb2b71c3c02bd5e3f480ef
Served dimensions: 543 × 700